Literature DB >> 32205880

Non-catalytic ubiquitin binding by A20 prevents psoriatic arthritis-like disease and inflammation.

Bahram Razani1,2, Michael I Whang1, Francis S Kim1,3, Mary C Nakamura1, Xiaofei Sun1, Rommel Advincula1, Jessie A Turnbaugh4, Mihir Pendse1, Priscilia Tanbun1, Philip Achacoso1, Peter J Turnbaugh4, Barbara A Malynn5, Averil Ma6.   

Abstract

A20 is an anti-inflammatory protein that is strongly linked to human disease. Here, we find that mice expressing three distinct targeted mutations of A20's zinc finger 7 (ZF7) ubiquitin-binding motif uniformly developed digit arthritis with features common to psoriatic arthritis, while mice expressing point mutations in A20's OTU or ZF4 motifs did not exhibit this phenotype. Arthritis in A20ZF7 mice required T cells and MyD88, was exquisitely sensitive to tumor necrosis factor and interleukin-17A, and persisted in germ-free conditions. A20ZF7 cells exhibited prolonged IκB kinase activity that drove exaggerated transcription of late-phase nuclear factor-κB response genes in vitro and in prediseased mouse paws in vivo. In addition, mice expressing double-mutant A20 proteins in A20's ZF4 and ZF7 motifs died perinatally with multi-organ inflammation. Therefore, A20's ZF4 and ZF7 motifs synergistically prevent inflammatory disease in a non-catalytic manner.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32205880      PMCID: PMC7195210          DOI: 10.1038/s41590-020-0634-4

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  48 in total

1.  Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells.

Authors:  Martijn J Schuijs; Monique A Willart; Karl Vergote; Delphine Gras; Kim Deswarte; Markus J Ege; Filipe Branco Madeira; Rudi Beyaert; Geert van Loo; Franz Bracher; Erika von Mutius; Pascal Chanez; Bart N Lambrecht; Hamida Hammad
Journal:  Science       Date:  2015-09-04       Impact factor: 47.728

2.  A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease.

Authors:  Florence A Aeschlimann; Ezgi D Batu; Scott W Canna; Ellen Go; Ahmet Gül; Patrycja Hoffmann; Helen L Leavis; Seza Ozen; Daniella M Schwartz; Deborah L Stone; Annet van Royen-Kerkof; Daniel L Kastner; Ivona Aksentijevich; Ronald M Laxer
Journal:  Ann Rheum Dis       Date:  2018-01-09       Impact factor: 19.103

3.  Haploinsufficiency of A20 causes autoinflammatory and autoimmune disorders.

Authors:  Tomonori Kadowaki; Hidenori Ohnishi; Norio Kawamoto; Tomohiro Hori; Kenichi Nishimura; Chie Kobayashi; Tomonari Shigemura; Shohei Ogata; Yuzaburo Inoue; Tomoki Kawai; Eitaro Hiejima; Masatoshi Takagi; Kohsuke Imai; Ryuta Nishikomori; Shuichi Ito; Toshio Heike; Osamu Ohara; Tomohiro Morio; Toshiyuki Fukao; Hirokazu Kanegane
Journal:  J Allergy Clin Immunol       Date:  2017-12-11       Impact factor: 10.793

Review 4.  A20: A multifunctional tool for regulating immunity and preventing disease.

Authors:  Barbara A Malynn; Averil Ma
Journal:  Cell Immunol       Date:  2019-04-05       Impact factor: 4.868

5.  Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice.

Authors:  E G Lee; D L Boone; S Chai; S L Libby; M Chien; J P Lodolce; A Ma
Journal:  Science       Date:  2000-09-29       Impact factor: 47.728

6.  The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.

Authors:  David L Boone; Emre E Turer; Eric G Lee; Regina-Celeste Ahmad; Matthew T Wheeler; Colleen Tsui; Paula Hurley; Marcia Chien; Sophia Chai; Osamu Hitotsumatsu; Elizabeth McNally; Cecile Pickart; Averil Ma
Journal:  Nat Immunol       Date:  2004-08-29       Impact factor: 25.606

Review 7.  Autosomic dominant familial Behçet disease and haploinsufficiency A20: A review of the literature.

Authors:  Florian Berteau; Bénédicte Rouviere; Aurélien Delluc; Alice Nau; Rozenn Le Berre; Guillaume Sarrabay; Isabelle Touitou; Claire de Moreuil
Journal:  Autoimmun Rev       Date:  2018-06-08       Impact factor: 9.754

Review 8.  A20 in inflammation and autoimmunity.

Authors:  Leen Catrysse; Lars Vereecke; Rudi Beyaert; Geert van Loo
Journal:  Trends Immunol       Date:  2013-11-15       Impact factor: 16.687

9.  Hypomorphic A20 expression confers susceptibility to psoriasis.

Authors:  Anri Aki; Miyuki Nagasaki; Barbara Ann Malynn; Averil Ma; Takashi Kagari
Journal:  PLoS One       Date:  2017-06-28       Impact factor: 3.240

10.  Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease.

Authors:  Qing Zhou; Hongying Wang; Daniella M Schwartz; Monique Stoffels; Yong Hwan Park; Yuan Zhang; Dan Yang; Erkan Demirkaya; Masaki Takeuchi; Wanxia Li Tsai; Jonathan J Lyons; Xiaomin Yu; Claudia Ouyang; Celeste Chen; David T Chin; Kristien Zaal; Settara C Chandrasekharappa; Eric P Hanson; Zhen Yu; James C Mullikin; Sarfaraz A Hasni; Ingrid E Wertz; Amanda K Ombrello; Deborah L Stone; Patrycja Hoffmann; Anne Jones; Beverly K Barham; Helen L Leavis; Annet van Royen-Kerkof; Cailin Sibley; Ezgi D Batu; Ahmet Gül; Richard M Siegel; Manfred Boehm; Joshua D Milner; Seza Ozen; Massimo Gadina; JaeJin Chae; Ronald M Laxer; Daniel L Kastner; Ivona Aksentijevich
Journal:  Nat Genet       Date:  2015-12-07       Impact factor: 38.330

View more
  22 in total

1.  Fanning the Flames of Autoimmunity: The Microbiome in Rheumatic Disease.

Authors:  Renuka R Nayak
Journal:  Arthritis Rheumatol       Date:  2022-02-10       Impact factor: 10.995

Review 2.  Deubiquitinases in cell death and inflammation.

Authors:  Kim Newton; Alexander D Gitlin
Journal:  Biochem J       Date:  2022-05-27       Impact factor: 3.766

Review 3.  Ankylosing spondylitis: an autoimmune or autoinflammatory disease?

Authors:  Daniele Mauro; Ranjeny Thomas; Giuliana Guggino; Rik Lories; Matthew A Brown; Francesco Ciccia
Journal:  Nat Rev Rheumatol       Date:  2021-06-10       Impact factor: 20.543

4.  Inhibitory feedback control of NF-κB signalling in health and disease.

Authors:  Jack A Prescott; Jennifer P Mitchell; Simon J Cook
Journal:  Biochem J       Date:  2021-07-16       Impact factor: 3.857

Review 5.  New Frontiers in Psoriatic Disease Research, Part I: Genetics, Environmental Triggers, Immunology, Pathophysiology, and Precision Medicine.

Authors:  Di Yan; Johann E Gudjonsson; Stephanie Le; Emanual Maverakis; Olesya Plazyo; Christopher Ritchlin; Jose U Scher; Roopesh Singh; Nicole L Ward; Stacie Bell; Wilson Liao
Journal:  J Invest Dermatol       Date:  2021-07-22       Impact factor: 8.551

Review 6.  Linear Ubiquitin Code: Its Writer, Erasers, Decoders, Inhibitors, and Implications in Disorders.

Authors:  Daisuke Oikawa; Yusuke Sato; Hidefumi Ito; Fuminori Tokunaga
Journal:  Int J Mol Sci       Date:  2020-05-11       Impact factor: 5.923

Review 7.  Lymphotropic Viruses: Chronic Inflammation and Induction of Cancers.

Authors:  Edward W Harhaj; Noula Shembade
Journal:  Biology (Basel)       Date:  2020-11-10

8.  A zebrafish functional genomics model to investigate the role of human A20 variants in vivo.

Authors:  Daniele Cultrone; Nathan W Zammit; Eleanor Self; Benno Postert; Jeremy Z R Han; Jacqueline Bailey; Joanna Warren; David R Croucher; Kazu Kikuchi; Ozren Bogdanovic; Tatyana Chtanova; Daniel Hesselson; Shane T Grey
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379

Review 9.  A20: a master regulator of arthritis.

Authors:  Yongyao Wu; Xiaomin He; Ning Huang; Jiayun Yu; Bin Shao
Journal:  Arthritis Res Ther       Date:  2020-09-21       Impact factor: 5.156

10.  Association of Clinical Phenotypes in Haploinsufficiency A20 (HA20) With Disrupted Domains of A20.

Authors:  Yu Chen; Zhenghao Ye; Liping Chen; Tingting Qin; Ursula Seidler; De'an Tian; Fang Xiao
Journal:  Front Immunol       Date:  2020-09-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.